What the $99 offer describes
The Wisp page states that the displayed $99 includes a consult and 90-day supply, with free delivery advertised. Dividing $99 by three gives $33 per 30 days. That calculation is a comparison aid, not evidence that Wisp bills in monthly installments or offers one month for $33.
Confirm the amount due for the actual order, whether the same terms apply at refill and whether an order renews automatically. Sitewide coupon banners may have eligibility conditions, so this review records the undiscounted displayed offer rather than assuming that every prospective buyer qualifies for an introductory promotion.
The price guide explains why 90 days and three calendar months should remain distinguishable. The price workspace preserves Wisp’s day-based supply period when showing an equivalent rate. It does not promise the same price for future orders or calculate a medically appropriate duration of treatment.
The formula still needs a complete record
The public offer identifies estriol as the relevant hormone. The material we could verify did not establish a complete patient-specific formula and active concentration. Ask for those details from the prescribing service and dispensing pharmacy before comparing strengths or adding the preparation to an existing routine.
A product photograph or another person’s prescription is not an adequate substitute for the preparation you would receive. Confirm the cream base, other ingredients and instructions, especially if you have a history of reactions. An estriol-only description should not be assumed to mean that the entire ingredient list contains nothing else.
This distinguishes the information available here from the specific active strengths on the sponsored CoreAge Rx Time Out page and the named two-active combination in Winona’s cream. A comparison can acknowledge an unresolved field without assigning a made-up value or treating missing public detail as proof of poor quality.
The age policy is not automatic eligibility
Wisp’s expanded FAQ says it prescribes this facial cream to people 35 and older, subject to its clinical process. The same answer notes limited long-term safety and efficacy research, particularly for women aged 35 to 40. That qualification belongs beside the age policy rather than being omitted after the minimum age is mentioned.
An eligibility threshold set by a service is not evidence that everyone above it needs the treatment or will benefit. The clinician still needs to assess the concern, medical history and other medicines. The prescription checklist explains how to keep a service’s intake rules separate from an individual clinical decision.
The public site also describes access across the United States. We have not independently verified prescribing availability for every person or every state-specific circumstance. Confirm the current route available to you before relying on a broad national-availability statement in a shopping comparison.
Read compatibility claims with the prescriber
Wisp’s FAQ says the cream can be used with other anti-aging products, including retinoids. That should not be interpreted as approval of every possible combination, amount or application schedule. A clinician needs the actual list of products already used and the proposed cream’s complete formulation.
Our estriol and tretinoin guide addresses this distinction. A statement that ingredients can appear in a treatment plan does not determine whether an individual should use them together, in separate products or at a particular frequency. The instructions attached to the prescription take precedence over a general review article.
Ask how to contact the clinical team if irritation or another concern occurs. Customer-service access and prescribing follow-up are related but different services. Establish who can change the treatment plan and what happens to a refill if the prescriber recommends reassessment.
Company reviews are not cream outcomes
The Wisp page displays company reviews, including experiences with services unrelated to facial skin care. Those comments may be relevant to aspects of the company’s service, but they should not be counted as successful treatment outcomes for Estriol Face Cream.
Similarly, a large company review count does not establish that the same number of people used this specific prescription. We do not convert that number or the displayed company rating into an effectiveness score. Our claims guide explains why the subject of a review matters as much as the star rating.
We did not identify a controlled trial of the exact offered Wisp formulation in the reviewed public materials. That does not establish that no further information is available. Ask the provider what research supports the proposed preparation and whether it matches the product, population and outcomes being discussed.
Keep the regulatory status explicit
The FDA’s menopause information states that no drugs containing estriol are FDA-approved. Compounded preparations are not FDA-approved finished drugs; the agency’s compounding explanation describes their different premarket review status.
A consultation included in the price is useful service information, but it does not replace these facts. The clinician should explain why a proposed preparation fits the individual situation and what uncertainties remain, including questions about other hormone therapy and systemic exposure.
What makes the offer comparable
Wisp supplies a clearly stated price and supply period, plus a published age policy with an evidence qualification. The remaining work is to confirm the exact preparation, personal eligibility, refill terms and clinical support. Those answers make the offer more comparable than its headline price alone.
Read the four-provider overview and Evernow review for a contrasting care-fee model. Use the comparison to prepare an informed discussion, rather than choosing a prescription solely because a normalized monthly number is smaller.